SynthesisRenal failure2023

An updated meta-analysis on the efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor treatment of anemia in nondialysis-dependent chronic kidney disease.

Hanxue Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.